Daehan New Pharm Co. Ltd. | Cash Flow
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,955
2,661
4,148
5,671
20,581
Depreciation, Depletion & Amortization
1,639
2,145
2,967
3,872
3,193
Funds from Operations
4,441
6,977
10,711
14,942
1,228
Changes in Working Capital
1,448
3,039
2,906
6,191
3,652
Net Operating Cash Flow
2,993
10,016
7,805
8,751
2,424
Capital Expenditures
3,356
6,886
3,972
4,888
1,275
Sale of Fixed Assets & Businesses
-
-
5
-
5
Purchase/Sale of Investments
63
580
31
3,653
1,109
Net Investing Cash Flow
4,551
4,936
4,285
1,534
470
Cash Dividends Paid - Total
-
-
-
-
702
Issuance/Reduction of Debt, Net
1,132
4,691
2,381
906
92
Net Financing Cash Flow
1,542
4,691
2,381
930
610
Net Change in Cash
16
389
1,138
6,286
3,852
Free Cash Flow
33
3,322
3,941
4,180
3,677
Deferred Taxes & Investment Tax Credit
-
118
217
658
5
Other Sources
194
1,369
-
-
23
Exchange Rate Effect
1
-
-
-
347
Other Uses
1,451
-
349
298
331
About Daehan New Pharm Co.
View Profile
